Claire Deselle
Président chez Maine Venture Fund
Profil
Claire Deselle is currently the Vice Chairman at Maine Venture Fund.
Prior to this, she worked as the President & Chief Executive Officer at CS-Keys, Inc. and as a Principal at Eli Lilly & Co. She holds an MBA from the University of Pennsylvania.
Postes actifs de Claire Deselle
| Sociétés | Poste | Début |
|---|---|---|
Maine Venture Fund
 Maine Venture Fund Investment ManagersFinance Maine Venture Fund is a venture capital firm founded in 1995. The firm is headquartered in Newport, Maine. | Président | - |
Anciens postes connus de Claire Deselle
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
CS-Keys, Inc.
 CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | President | - |
Formation de Claire Deselle
| University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | Health Technology |
Maine Venture Fund
Maine Venture Fund Investment ManagersFinance Maine Venture Fund is a venture capital firm founded in 1995. The firm is headquartered in Newport, Maine. | Finance |
